Buscar
Mostrando ítems 41-50 de 1247
Characterization of SARS-CoV-2 Dynamics in the Host
(Pergamon-Elsevier Science Ltd, 2020-06)
While many epidemiological models were proposed to understand and handle COVID-19 pandemic, too little has been invested to understand human viral replication and the potential use of novel antivirals to tackle the infection. ...
Temporalidad de la vacunación contra SARS-CoV-2 entre la segunda dosis y la dosis de refuerzo - Nota Técnica
(Instituto Nacional de Salud, 2021-12)
La presente nota técnica tiene como objetivo describir la evidencia científica publicada respecto al intervalo de tiempo que debe transcurrir entre la segunda dosis y la dosis de refuerzo (tercera dosis) de la vacuna contra ...
Antiviral Properties of Food Plants Could Help to Reduce Contagion and Severity in SARS-CoV-2 Infections
(Bentham Science Publishers, 2022-01)
Introduction: The importance of an immediate tool to help patients and prevent viral diffusion of new pneumonia caused by 2019 novel coronavirus (2019-nCoV or SARS-CoV-2) that causes the disease COVID-19 becomes evident. ...
Biogenic production of silver, zinc oxide, and cuprous oxide nanoparticles, and their impregnation into textiles with antiviral activity against SARS-CoV-2
(Nature Publishing GroupPECR, 2023-06-16)
Nanotechnology is being used to fight off infections caused by viruses, and one of the most outstanding nanotechnological uses is the design of protective barriers made of textiles functionalized with antimicrobial agents, ...
Utilización de altas dosis de ácido ascórbico en el tratamiento del SARS Covid-19: Soporte Científico y Clínico para su aplicación en terapéuticaHigh Dose Of Ascorbic Acid Used In Sars Covid-19 Treatment: Scien-tific And Clinical Support For Its Therapeutic Implementation
(Universidad de Granada, 2020-04)
El coronavirus 2019 (SARS-CoV-2) ha sido declarado una emergencia de salud pública de impacto in-ternacional por la Organización Mundial de la Salud. Debido a la aparición repentina de este proceso pandémico ...
Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine
(2021)
BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus responsible of the current pandemic ongoing all around the world. Since its discovery in 2019, several circulating variants have emerged ...
Genetics of COVID-19
Objective: This narrative, non-systematic review provides an update on the genetic aspects of
the SARS-CoV-2 virus and its interactions with the human genome within the context of
COVID-19. Although the main focus is on ...
Variantes del SARS-CoV-2: epidemiología, fisiopatología y la importancia de las vacunas
(Instituto Nacional de Salud (Peru), 2021-10-13)
El SARS-CoV-2 es un virus ARN monocatenario de la familia de los coronavirus, causante de la COVID-19 (Coronavirus Disease 2019). Este virus es responsable de la pandemia actual que, desde su aparición a finales de 2019, ...